PANAGORA ASSET MANAGEMENT INC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,919,000
+35.9%
95,203
+151.6%
0.01%
+25.0%
Q2 2021$1,412,000
-71.6%
37,838
-80.5%
0.01%
-71.4%
Q1 2021$4,965,000
-25.0%
194,166
-35.4%
0.03%
-28.2%
Q4 2020$6,620,000
+407.7%
300,504
+314.7%
0.04%
+387.5%
Q3 2020$1,304,000
-62.3%
72,469
-46.8%
0.01%
-63.6%
Q2 2020$3,462,000
-51.1%
136,311
-64.6%
0.02%
-56.0%
Q1 2020$7,074,000
+12532.1%
385,067
+14965.2%
0.05%
Q4 2019$56,000
+47.4%
2,556
-3.4%
0.00%
Q3 2019$38,000
-96.9%
2,645
-97.3%
0.00%
-100.0%
Q2 2018$1,216,000
+1588.9%
99,233
+1217.3%
0.01%
Q1 2018$72,000
+5.9%
7,5330.0%0.00%
Q4 2017$68,000
+172.0%
7,533
+74.5%
0.00%
Q3 2017$25,000
+47.1%
4,318
-17.7%
0.00%
Q2 2017$17,000
-5.6%
5,2440.0%0.00%
Q1 2017$18,000
-77.8%
5,244
-23.1%
0.00%
Q4 2015$81,000
+5.2%
6,819
-27.3%
0.00%
Q3 2015$77,000
+60.4%
9,379
+174.1%
0.00%
Q2 2015$48,0003,4220.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 2,005,238$16,463,0005.12%
Abingworth LLP 945,757$7,755,0004.53%
RA Capital Management 2,428,571$19,939,0002.86%
Omega Fund Management, LLC 223,457$1,835,0001.03%
DAFNA Capital Management LLC 123,500$1,014,0001.01%
Iguana Healthcare Management, LLC 100,000$821,0000.32%
Cormorant Asset Management, LP 245,000$2,011,0000.32%
Eventide Asset Management 315,300$2,589,0000.15%
AWM Investment Company, Inc. 80,000$657,0000.13%
Palo Alto Investors LP 267,890$2,199,0000.11%
View complete list of DICERNA PHARMACEUTICALS INC shareholders